BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 4403346)

  • 1. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
    Scebat L; Bensaid J
    Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial using the beta receptor blockader Visken].
    Szám I; Holló J
    Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 5. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T; Aquaro G
    Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anaprilin in stenocardia and arrhythmia].
    Zharko KP; Lebedev SV; Simon IB
    Klin Med (Mosk); 1972 Feb; 50(2):57-60. PubMed ID: 4401948
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-receptor blockader LB 46 in the therapy of tachycardial arrhythmias].
    Novosel D
    Med Monatsschr; 1970 Oct; 24(10):466-71. PubMed ID: 4097485
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of arrhythmias with pindolol.
    Aronow WS; Uyeyama RR
    Clin Pharmacol Ther; 1972; 13(1):15-22. PubMed ID: 4400146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H; Ducloux G
    Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of alprenolol in the treatment of angina pectoris].
    Lippenholtz A; Talmasky S; Berconsky I
    Prensa Med Argent; 1969 Sep; 56(27):1357-61. PubMed ID: 4391256
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug.
    Bauer GE; Michell G
    Med J Aust; 1970 Jan; 1(4):170-3. PubMed ID: 4190852
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of heart arrhythmias with a beta adrenergic blocking agent: Ciba 39,089 Ba].
    Maranhão MF; Lacerda FS; de Cicco LA; Cunha GP
    Arq Bras Cardiol; 1970 Oct; 23(5):327-34. PubMed ID: 4396431
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
    Gasparotto G; Pagnan A
    Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 19. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta-blocking agents in angina pectoris. A double-blind trial].
    Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.